Nanotechnology Now - News Story: BioSante Encouraged by FDA Panel on Exubera

Home > News > BioSante Encouraged by FDA Panel on Exubera

September 21st, 2005

BioSante Encouraged by FDA Panel on Exubera

Abstract:
Mr. Simes said development continues on BioSante's inhalable insulin product using the company's proprietary BioAir(TM) calcium phosphate nanoparticulate (CaP) delivery system.

Source:
businesswire

Bookmark:

Related News Press

Possible Futures

Researchers demonstrates substrate design principles for scalable superconducting quantum materials: NYU Tandon–Brookhaven National Laboratory study shows that crystalline hafnium oxide substrates offer guidelines for stabilizing the superconducting phase October 3rd, 2025

Gap-controlled infrared absorption spectroscopy for analysis of molecular interfaces: Low-cost spectroscopic approach precisely analyzes interfacial molecular behavior using ATR-IR and advanced data analysis October 3rd, 2025

Spinel-type sulfide semiconductors to operate the next-generation LEDs and solar cells For solar-cell absorbers and green-LED source October 3rd, 2025

Breaking barriers in energy-harvesting using quantum physics: Researchers find a way to overcome conventional thermodynamic limits when converting waste heat into electricity October 3rd, 2025

Nanomedicine

New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025

New imaging approach transforms study of bacterial biofilms August 8th, 2025

Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025

Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025

Announcements

Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025

Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025

Next-generation quantum communication October 3rd, 2025

"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025



Premium Products


	Only the news you want to read! Learn More



	Full-service, expert consulting Learn More




	The latest news from around the world, FREE